Oppenheimer analyst Chris Kotowski downgraded Carlyle (CG) to Perform from Outperform.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Carlyle Group (CG) Descends Despite Hopes of $5B IPO Bonanza
- Biotech Alert: Searches spiking for these stocks today
- NSM Insurance to sell U.S. commercial insurance division to New Mountain Capital
- Bluebird Bio price target lowered to $5 from $40 at Wells Fargo
- Bluebird Bio to be acquired by Carlyle, SK Capital for $3.00 per share